Online Appendices
Files in this Data Supplement:
- Appendix 1: Drug plan formulary decisions based on 53 Common Drug Review recommendations
- Appendix 2: Time-to-listing for 53 drugs with a Common Drug Review recommendation, stratified by provincial and federal drug plan review times
- Appendix 3: Agreement between 87 Common Drug Review recommendations and drug plan listing decisions